Northern Trust Corp Cabaletta Bio, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 388,004 shares of CABA stock, worth $970,010. This represents 0.0% of its overall portfolio holdings.

Number of Shares

388,004

Previous 306,408 26.63%

Holding current value

$970,010

Previous $2.29 Million 20.08%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.94 - $8.24 $321,488 - $672,351	81,596 Added 26.63%	388,004 $1.83 Million
Q2 2024 Aug 14, 2024	BUY	$7.22 - $18.82 $16,223 - $42,288	2,247 Added 0.74%	306,408 $2.29 Million
Q1 2024 May 14, 2024	SELL	$16.79 - $25.38 $109,319 - $165,249	-6,511 Reduced 2.1%	304,161 $5.19 Million
Q4 2023 Feb 13, 2024	BUY	$12.21 - $23.36 $133,125 - $254,694	10,903 Added 3.64%	310,672 $7.05 Million
Q3 2023 Nov 13, 2023	BUY	$11.84 - $18.65 $1.01 Million - $1.59 Million	85,287 Added 39.76%	299,769 $4.56 Million
Q2 2023 Aug 11, 2023	BUY	$7.65 - $13.95 $1.33 Million - $2.43 Million	174,335 Added 434.24%	214,482 $2.77 Million
Q1 2023 May 15, 2023	BUY	$7.08 - $12.62 $42,133 - $75,101	5,951 Added 17.4%	40,147 $332,000
Q4 2022 Feb 13, 2023	BUY	$0.64 - $9.3 $3,128 - $45,467	4,889 Added 16.68%	34,196 $316,000
Q4 2021 Feb 08, 2022	BUY	$3.36 - $14.64 $14,572 - $63,493	4,337 Added 17.37%	29,307 $111,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $3,857 - $6,887	-551 Reduced 2.16%	24,970 $304,000
Q2 2021 Aug 13, 2021	SELL	$7.2 - $11.73 $753,458 - $1.23 Million	-104,647 Reduced 80.39%	25,521 $219,000
Q1 2021 May 12, 2021	SELL	$10.39 - $14.53 $98,258 - $137,410	-9,457 Reduced 6.77%	130,168 $1.45 Million
Q4 2020 Feb 11, 2021	SELL	$9.81 - $15.8 $49,775 - $80,169	-5,074 Reduced 3.51%	139,625 $1.74 Million
Q3 2020 Nov 16, 2020	BUY	$9.71 - $14.41 $136,648 - $202,791	14,073 Added 10.77%	144,699 $1.57 Million
Q2 2020 Aug 14, 2020	BUY	$6.39 - $11.28 $212,090 - $374,394	33,191 Added 34.06%	130,626 $1.46 Million
Q1 2020 May 14, 2020	BUY	$6.0 - $18.67 $181,224 - $563,908	30,204 Added 44.93%	97,435 $712,000
Q4 2019 Feb 14, 2020	BUY	$7.88 - $17.71 $529,780 - $1.19 Million	67,231 New	67,231 $939,000

Others Institutions Holding CABA

# of Institutions

126

Shares Held

47.9M

Call Options Held

202K

Put Options Held

110K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $72.5M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Cabaletta Bio, Inc. Transaction History